Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses Available Targeted Therapies
OncLive TV
Dr. Roy S. Herbst from Yale comprehensive cancer center on the International Lung Cancer Congress
Advertisement
Dr. Axel Hoos medical lead at Bristol-Myers Squibb Discusses the Next Steps for Ipilimumab
Dr. Roy Herbst from the Yale Comprehensive Cancer Center on Screening Studies at the Upcoming Lung Cancer Congress
Dr. Jack West from the Swedish Cancer Institute Talks About the Escalating Cost of Cancer Care
Dr. Axel Hoos medical lead at Bristol-Myers Squibb Discusses Which Patients are Eligible to Receive Ipilimumab
Advertisement
Dr. Allen S. Lichter the chief executive officer of ASCO on the Importance of the UN Summit on NCD
Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses Patient Acceptance of Mutation Testing
Dr. Jack West from the Swedish Cancer Institute Talks About Anticipated Future Clinical Trials
Dr. Sandhya Pruthi from the Mayo Clinic in Minnesota on What She Learned From the Flaxseed Trial
Dr. Axel Hoos medical lead at bristol-myers squibb on the Ipilimumab Plus Dacarbazine Combination Trial
Dr. Allen S. Lichter the CEO of the American Society of Clinical Oncology (ASCO) on how they Address the World's Cancer Issues
Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center on How the Institutes in the mutlicenter study examining driver mutations Worked Together
Dr. Jack West from Swedish Cancer Institute Discusses 4 Important Upcoming Clinical Trials Results in Lung Cancer.
Dr. Apostolia Tsimberidou from MD Anderson Cancer Center on the Next Steps for Personalized Care
Donna Berry Describes the Electronic Self-Report Assessment for Cancer (ESRA-C) Program
Kristie Howlett from Sutter Roseville Medical Center on her Patient Hand Wiping Trial
Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses the Field of Mutation Testing
Dr. Axel Hoos medical lead at Bristol-Myers Squibb on Why Melanoma is Amenable to Immunotherapy
Dr. Allen S. Lichter the CEO of ASCO Urges President Obama to Attend the UN Non-Communicable Diseases Conference
Reynaldo Garcia From Lineberger Comprehensive Cancer Center on CML BCR-ABL Testing Recommendation
Dr. Sandya Pruthi from the Mayo Clinic in Minnesota Examines the Options Available for Hot Flashes after the failure of flaxseed
Dr. Mark G. Kris from Memorial Sloan-Kettering cancer center Explains How Gene Signatures are Used
Dr. Brian I. Rini from the Taussig Cancer Institute Describes Hypertension as a Biomarker in RCC
Dr. Jack West from Swedish Cancer Institute Explains the Pemetrexed Clinical Trial
Dr. Apostolia M. Tsimberidou from MD Anderson Cancer Center on the Personalized Medicine Study Results
Dr. Allen S. Lichter CEO of ASCO on the upcoming UN Summit for Non-Communicable Diseases
Karen Hagemaster from Advocate Good Samaritan Hospital on Chemotherapy Documentation Study
Dr. Nicholas J. Vogelzang from the Comprehensive Cancer Centers of Nevada Discusses the Cabozantinib Trial Design
Dr. Mark G. Kris thoracic chair at Memorial Sloan-Kettering Cancer Center Discusses Driver Mutations Test False Negatives
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5